Pharma and Biotech
Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -1027.9% | n/a |
ROCE | 4172.7% |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | 29.0 | n/a |
Pr/Book | n/a |
Latest | F'cast | |
---|---|---|
Revenue | -84.0% | n/a |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Mar-21 | 0.32 | (5.90) | (3.05)p | n/a | n/a | n/a | n/a | 0.0% |
31-Mar-22 | 0.62 | (5.57) | (2.65)p | n/a | n/a | n/a | n/a | 0.0% |
31-Mar-23 | 0.08 | (4.26) | (1.75)p | n/a | n/a | n/a | n/a | 0.0% |
31-Mar-24 | 1.91 | (3.01) | (0.87)p | n/a | n/a | n/a | n/a | 0.0% |
31-Mar-25 | 0.31 | (3.29) | (0.65)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Holding(s) in Company | 05-Sep-2025 | 11:00 | RNS |
Chill Appointed UK Distribution Partner by RELX | 01-Sep-2025 | 07:00 | RNS |
Holding(s) in Company | 22-Aug-2025 | 12:30 | RNS |
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 1.75p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 2.15 |
52 Week Low | 1.10 |
Volume | 2,075,117 |
Shares Issued | 506.29m |
Market Cap | £8.86m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
15:45 | 2,763 @ 1.80p |
15:26 | 10,000 @ 1.72p |
15:20 | 4,164 @ 1.80p |
15:19 | 50,000 @ 1.77p |
15:17 | 9,741 @ 1.72p |
You are here: research